Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 381-400 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 381 | Star Catcher Industries, Inc. lowweak | Opp 1 Risk 2 | Thesis: There is insufficient reviewed evidence in these reviewed sources to support an opportunity thesis beyond a broad statement that the company is building space infrastructure. Why now: Why now is weak because the reviewed sources' membership rationale references article describing an orbital power grid concept, but no article or reviewed evidence are provided for ranking use. Caveats: No article is available for article. Coverage debug shows zero evidence after recent evidence window. Cannot elevate concept relevance into thesis attractiveness without direct business evidence. |
| 382 | Star Catcher Industries, Inc. lowweak | Opp 1 Risk 1 | Thesis: Reviewed evidence-level rationale suggests Star Catcher is a space startup building space-based power infrastructure, but the ranking reviewed sources provide no direct positive evidence retained inside the 90-day recent evidence window, so there is insufficient basis for a positive 1 year+ opportunity thesis from admissible evidence. Why now: Why now is weak because the company had 10 articles considered, but zero article IDs and zero evidence remained after the 90-day recent evidence window cutoff of March 29, 2026; recency-based business-state judgment is therefore unavailable from these reviewed sources. Caveats: No retained evidence after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Phase-2 membership rationale is not directional proof and cites support article IDs without, so it cannot be used as a fully cited factual thesis. |
| 383 | Starfighters Space lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources rationale suggests Starfighters Space has air-launch and hypersonic testing relevance, but no within the recent evidence window direct evidence or citable are present in the reviewed sources output, so that does not support a scored positive thesis here. Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Starfighters Space. Caveats: Phase-2 membership rationale references multiple article IDs, but the reviewed sources provide no article for citation. |
| 384 | Starfish Space lowweak | Opp 1 Risk 1 | Thesis: Membership rationale indicates autonomous proximity-operations progress, but no retained 90-day direct positive evidence is available in the served reviewed sources to support a durable upside thesis. Why now: No retained article IDs or evidence remain after recent evidence filtering, so there is no current evidence-based catalyst in the reviewed sources. Caveats: Single-article historical context is not retained within the recent evidence window. Absence of negative evidence is not positive evidence. Scoring is conservative because the current reviewed sources is effectively ungrounded for direction. |
| 385 | Starlab lowweak | Opp 1 Risk 1 | Thesis: No positive thesis is supportable because the reviewed sources retains no direct positive evidence within the recent evidence window. Why now: Why now is weak: the reviewed sources indicates zero evidence after recent evidence window, so there is no retained current catalyst or current operating-state evidence for Starlab. Caveats: Coverage after recent evidence window is empty for this company. Phase-2 membership rationale references, but no article summary or quoted evidence is included in the retained reviewed sources, so it cannot be used for factual claims here. |
| 386 | StatSat lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not retain sufficient company-specific positive evidence to support an opportunity thesis. Why now: The membership rationale references article and says AISSat-4 is operated by StatSat, but no retained evidence or are present after recent evidence window, leaving recency and business impact uncertain. Caveats: The only described support is a limited operational reference, not a clear catalyst. No direct dated evidence row is retained in the reviewed sources. |
| 387 | Swedish Space Corporation lowweak | Opp 1 Risk 1 | Thesis: No supported positive thesis from the retained recent evidence window evidence. The reviewed sources only notes an indirect mention of international partnerships involving Sweden in a Firefly earnings transcript summary, without clearly establishing Swedish Space Corporation's role or business impact (: no provided in reviewed sources). Why now: There is no current catalyst supported by retained evidence. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency and business-state changes cannot be assessed from these reviewed sources. Caveats: No current evidence is provided for the cited support article in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Phase2 rationale is weaker than direct company-specific event evidence and should not be treated as strong proof. |
| 388 | Swoop Technologies lowweak | Opp 1 Risk 1 | Thesis: The only reviewed sources support is review-status context that Swoop was placed among Golden Dome contract awardees for networking/simulation, which could indicate defense/space-adjacent participation, but there is no direct positive evidence row or in the reviewed sources to support a durable opportunity thesis (: not provided in reviewed sources). Why now: No inside-recent evidence window evidence are available, and the reviewed sources reports articles after recent evidence window = 0 and evidence after recent evidence window = 0, so there is no supported near-term or long-horizon timing catalyst beyond generic context. Caveats: Single-article company universe but no representative article content or provided. Contract-award framing comes only through membership rationale, not direct evidence. No materiality, scale, or timing detail is available. |
| 389 | TelePIX lowweak | Opp 1 Risk 1 | Thesis: Reviewed evidence membership rationale suggests TelePIX is a space AI solutions company partnering on a VLEO satellite mission with an optical payload, which could imply long-horizon product or mission traction, but the reviewed sources provide no retained article summaries or direct positive evidence within the 90-day recent evidence window to support a stronger opportunity case. Why now: Why now is weak because coverage data shows zero articles after recent evidence window and zero evidence after recent evidence window, so there is no current retained catalyst evidence in the last 90 days despite membership support referencing article Caveats: Support exists only in the membership rationale, which cites article: but no or article summary is provided in the reviewed sources, so it cannot be cited as a factual claim under the the evidence standard. Evidence recent evidence review shows kept_rows 0 and coverage data shows evidence after recent evidence window 0. |
| 390 | Telesat Corp lowweak | Opp 1 Risk 1 | Thesis: No retained within the recent evidence window direct positive evidence is available in the reviewed sources, so there is not enough support for an opportunity thesis despite cohort relevance. Why now: Coverage data reports zero article IDs after recent evidence window and zero evidence after recent evidence window, preventing a recency-based ranking call. Caveats: Membership rationale references satellite communications and Lightspeed progress, but no article or retained evidence are supplied for ranking use. Public company status does not itself create a thesis without evidence. |
| 391 | Terran Orbital lowweak | Opp 1 Risk 2 | Thesis: The only reviewed sources support is a membership rationale stating Lockheed's modular satellite platform leverages Terran Orbital production, which suggests manufacturing relevance, but there is no in-window company evidence to support a stronger opportunity call. Why now: There is no valid near-term or long-horizon catalyst from the reviewed sources because coverage data shows zero evidence after recent evidence window; current state cannot be confirmed from local evidence. Caveats: No evidence remained after the 90-day recent evidence window. The reviewed sources includes only sparse membership rationale, not current direct evidence. |
| 392 | TESAT lowweak | Opp 1 Risk 1 | Thesis: TESAT appears in the reviewed sources only as a partner in Kepler Communications' ESA optical communications contract. Because relations are context-only in these reviewed sources, that cannot be used as direct counterparty propagation evidence, leaving no direct positive thesis support for TESAT itself (: not provided in reviewed sources). Why now: No inside-recent evidence window direct evidence are available, so there is no supported timing argument. Caveats: Relation evidence is context-only and cannot be propagated as direct contract evidence. No or representative article summary is provided. No company-specific materiality data is available. |
| 393 | TESAT Spacecom lowweak | Opp 1 Risk 1 | Thesis: TESAT Spacecom is only referenced in prior HydRON contract context involving other companies, which is too indirect to support a positive thesis under the the evidence standard. Why now: There is no within the recent evidence window direct company evidence. Membership rationale references, but no is provided and the support level is only provisional single-article context. Caveats: Support is explicitly supporting article context, not direct company-specific event evidence. No retained evidence after recent evidence window. Relations/context-only mentions cannot be used as counterparty propagation evidence. |
| 394 | Thales lowweak | Opp 1 Risk 1 | Thesis: A weak opportunity case exists only from the phase2 rationale, which says Thales Alenia Space was linked as prime contractor for Sentinel-1 Next Generation satellites, suggesting satellite manufacturing/radar exposure. However, the reviewed sources provide no available article summaries or evidence inside recent evidence window for Thales itself, and the rationale itself questions whether subsidiary evidence should propagate to the parent. Why now: There is no citable in-recent evidence window article summary or evidence row for Thales in these reviewed sources, and coverage data shows zero article ids after recent evidence window and zero evidence after recent evidence window. Caveats: Phase2 rationale references article ids: and: but no or summaries for them are included here. Parent/subsidiary propagation is explicitly uncertain in the reviewed sources rationale. No direct evidence were available after recent evidence window. |
| 395 | Trishul Space lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only says Trishul Space was placed in T-Hub's ORBIT spacetech accelerator context, which is not enough by itself to establish a durable positive 1 year+ thesis without direct company-specific progress evidence. Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Trishul Space. Caveats: Phase-2 membership rationale references article: but the reviewed sources provide no for citation. Accelerator participation context is weaker than direct commercial, funding, or technical milestone evidence. |
| 396 | True Anomaly Centennial lowweak | Opp 1 Risk 1 | Thesis: Potential long-horizon opportunity cannot be established from available evidence. The reviewed sources membership rationale says the company was selected in the U.S. Space Force Andromeda contract for space surveillance, but no direct within the recent evidence window evidence or article details are available for scoring. Why now: Why-now visibility is weak because the reviewed sources show zero evidence kept after recent evidence window for this company, so any claimed contract relevance lacks scoreable supporting detail in the current batch. Caveats: Reviewed evidence cites: in membership rationale but does not provide article summary or available evidence, so it cannot be used as direct scoring evidence. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Absence of negative evidence is not positive evidence. |
| 397 | ULA lowweak | Opp 1 Risk 1 | Thesis: ULA is identified as a launch provider in membership context, but the reviewed sources retains no 90-day positive evidence to support an investable long-horizon opportunity view. Why now: Coverage data shows zero retained article IDs and evidence after the recent evidence filter, so there is no recent thesis-driving evidence in the reviewed sources. Caveats: Only membership-level context is present in the served reviewed sources. No direct event, fact, or article-context evidence remains within the recent evidence window. Direction cannot be inferred from category membership alone. |
| 398 | Uncovr lowweak | Opp 1 Risk 1 | Thesis: A funding-roundup mention suggests some financing activity, but the reviewed sources have no usable direct positive evidence after recent evidence window and does not connect the company to a space-specific thesis. Why now: The only described context is a funding-roundup article referenced in phase2 rationale, but no post-recent evidence window evidence or are provided for thesis use. Caveats: Phase2 rationale says Uncovr was listed as having raised $7M in article: but no was provided in the reviewed sources. Despite support_counts mentioning dated event/facts, the company-level available evidence arrays are empty and coverage data shows evidence after recent evidence window = 0. Broad funding roundup context is weaker than direct company-specific event evidence. |
| 399 | United Launch Alliance lowweak | Opp 1 Risk 1 | Thesis: Insufficient admissible reviewed sources evidence to support a positive thesis within the 90-day recent evidence window, despite membership rationale identifying ULA as a rocket company tied to Vulcan and Atlas V contexts. Why now: Why now is unsupported because the reviewed sources contain no surviving article or evidence after the selected recent evidence window; business-state or catalyst timing cannot be judged from the provided materials. Caveats: Zero evidence survived after recent evidence filtering. Company membership in the cohort is not thesis attractiveness. No dated catalyst, performance update, or direct risk item is included. |
| 400 | Univity lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources indicates Univity is a satellite startup that raised capital and plans a large VLEO constellation, but no dated within the recent evidence window evidence or article summaries are available here to support a stronger positive thesis. Why now: No usable within the recent evidence window evidence were available after filtering; recency-based thesis formation is therefore not supported in these reviewed sources. Caveats: Coverage after recent evidence window is effectively empty in these reviewed sources. Membership rationale is not directional proof. |
Risk view
Showing rows 1-20 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 1 | Blue Origin mediummedium | Opp 6 Risk 7 | Thesis: Execution risk is elevated because the same recent evidence set documents a New Glenn launchpad explosion on May 28, 2026, creating material uncertainty around launch reliability and schedule even though government customers reaffirmed support. Why now: The setup is active and recent: on May 30, 2026 SpaceNews reported Blue Origin received an NSSL task order hours before a New Glenn explosion, while on May 27, 2026 GeekWire reported New Glenn was preparing to return to service for an Amazon Leo mission after its first launch failure; on May 26, 2026 Investing.com summarized a NASA moon-base contract with launch no earlier than fall 2026 Evidence
Caveats: Positive evidence is mostly supporting article context rather than direct events. One external article is undated and is not relied on for recency proof. Government support after the anomaly partially offsets, but does not erase, execution risk. |
| 2 | Katalyst Space Technologies highstrong | Opp 8 Risk 6 | Thesis: Risk is also elevated because the mission profile is technically ambitious and schedule-sensitive: the rescue concept is framed as potentially the first time a commercial robotic spacecraft docks with an unprepared government satellite, and the telescope is described as at risk of deorbit by late 2026, implying high execution stakes. Why now: Why now is strong because the latest dated evidence on June 23, 2026 adds new capital after the May 29, 2026 NASA-related mission context, supporting a 1 year+ thesis that the company is moving from concept credibility toward funded development in on-orbit servicing. Evidence
Caveats: Part of the positive case comes from company-issued materials and supporting article context rather than independent positive evidence. The May 29, 2026 article includes a dated source date but describes an announcement text beginning 'August 11, 2025'; chronology should therefore be read carefully, with the treated as the recency marker for this retrieved item. Citation |
| 3 | Anduril Industries mediummedium | Opp 7 Risk 5 | Thesis: Risk remains elevated because the reviewed sources' evidence is mostly supporting article context rather than company-specific positive evidence, and program participation does not confirm revenue realization, production conversion, or margin outcomes. The capital raise also implies a company still in heavy scale-up mode rather than de-risked execution. Why now: The timing is supported by recent 2026 article context around Space Force Andromeda participation and the June 19, 2026 financing context, which together suggest active momentum over the last quarter. Evidence
Caveats: Most evidence is weak context-only article evidence, not direct positive events in the available ranking rows. |
| 4 | AST SpaceMobile, Inc. highstrong | Opp 8 Risk 5 | Thesis: Risk remains elevated because the thesis still depends on large-scale deployment and commercialization execution; the reviewed sources show authorization and partnerships, but limited direct proof of broad revenue conversion or completed network rollout inside the recent evidence window. Why now: The key timing event is the FCC authorization dated April 21, 2026/April 22, 2026 granting authority for up to 248 satellites and direct-to-device service, a milestone that can unlock U.S. commercial and government use cases over a 1 year+ horizon. Later-dated company-site context on June 23, 2026 also says AST has nearly 60 operator partners and targets direct broadband to standard smartphones. Evidence
Caveats: Much of the evidence is company, press-release, or article-context based rather than independent hard performance metrics. The reviewed sources cites a target of 45 to 60 BlueBird satellites by end-2026 in article summary context, but this is not available as a direct structured fact here. |
| 5 | Atomic-6 lowweak | Opp 4 Risk 5 | Thesis: Risk is moderate because none of the underlying article summaries or are provided in the visible evidence section, so the apparent positives cannot be independently grounded from the reviewed sources output beyond the rationale text. Why now: The reviewed sources rationale cites article and says Atomic-6 launched an orbital data center service and has DoD and U.S. Space Force contracts, but no representative article or is provided in the visible reviewed sources, so timing confidence is limited. Caveats: No direct evidence or article are available in the reviewed sources body. Opportunity thesis relies on membership rationale rather than citable article summary. Because the underlying evidence is not exposed, conviction must stay low. |
| 6 | Intuitive Machines, Inc. mediummedium | Opp 6 Risk 5 | Thesis: Risk is also moderate because the evidence is lighter than for top-ranked names and the key contract appears to be an IDIQ selection/competition vehicle rather than a clearly quantified standalone revenue award in the reviewed sources. Why now: The timing case comes from May 12, 2026 reporting that Intuitive Machines was selected for the Space Force Andromeda IDIQ to develop space surveillance capabilities through 2030 and beyond, described as the company's first major selection following the Lanteris Space acquisition. Evidence
Caveats: The reviewed sources provide supporting article context but no direct structured fact with quantified contract value specific to Intuitive Machines. No direct adverse evidence is available; risk is based on competitive award structure and evidence limitations. Long-horizon upside depends on conversion from selection status into meaningful programs. |
| 7 | Momentus mediummedium | Opp 7 Risk 5 | Thesis: Risk remains elevated because the evidence set emphasizes announcements and pipeline/contract positioning rather than broad proof of scaled recurring commercial adoption; some supportive contract context, including SHIELD selection, is older than the recent evidence window and should not be over-weighted for recency. Why now: Why-now is supported by recent mission and contract evidence within the recent evidence window: on March 30, 2026 Momentus announced the successful launch of Vigoride 7 and called it its most advanced on-orbit demonstration campaign to date; on June 17, 2026 it announced a new commercial contract with LASP to host and operate the OWLS mission on Vigoride-9, expanding its commercial revenue portfolio. Evidence
Caveats: The SHIELD contract-vehicle selection is dated December 10, 2025 and outside the 90-day recent evidence window, so it is useful background but not a recency catalyst here. Some weak context rows repeat the same article-level claims and are not independent confirmation. |
| 8 | Momentus Inc lowweak | Opp 4 Risk 5 | Thesis: Momentus receives the highest risk score in the thin-evidence group because the reviewed sources references a commercial contract but provides no current available corroboration, leaving substantial uncertainty around execution, financing durability, and contract conversion. This is still an evidence-gap risk, not a confirmed adverse-event thesis, because no direct negative evidence is available (: and: unavailable in reviewed sources). Why now: Why now is medium because an orbital services contract can matter over a 1 year+ horizon, but the reviewed sources' post-recent evidence window evidentiary absence prevents stronger timing confidence. Caveats: No direct evidence remained after the recent evidence filter. |
| 9 | Orbex mediumweak | Opp 1 Risk 5 | Thesis: Risk is moderate because the only described usable context says the company was looking to secure its future, while all dated evidence shown is outside the allowed recent evidence window, leaving the current business state uncertain. Why now: The only surfaced article is dated February 17, 2026, outside the reviewed sources cutoff date of March 29, 2026, and the evidence recent evidence review says both rows were dropped; the article summary said Orbex released new photographs of its microlauncher Prime 'as the company looks to secure a future'. Because this is outside recent evidence window, recency support is absent. Evidence
Caveats: Primary surfaced evidence is outside recent evidence window and should not be treated as current proof. No in-recent evidence window direct positive or negative evidence is available. |
| 10 | Orbital Inc. mediummedium | Opp 6 Risk 5 | Thesis: Risk is moderate because the reviewed sources provide only supporting article context and no direct evidence of contracts, deployment milestones, customer traction, or technical validation beyond the funding/context claim. Why now: The usable evidence is recent within the 90-day recent evidence window: an April 14, 2026 article said Orbital got funded by Andreessen Horowitz to verify its space-based data center concept, which is relevant to a 1 year+ horizon because financing can support technology proof and strategic positioning Evidence
Caveats: Evidence is supporting article context/weak context rather than direct positive events. No reviewed sources evidence of customers, revenue, launch schedule, or technical milestone completion. Same article appears in multiple weak-context rows and should not be treated as independent confirmation. |
| 11 | Quantum Space mediummedium | Opp 8 Risk 5 | Thesis: The company still carries meaningful execution and transaction risk because the SPAC deal is only expected to close in the fourth quarter rather than already complete, contract value was undisclosed, and key program delivery is pushed out to 2028, leaving room for financing, closing, and execution slippage. Why now: The evidence is recent and sequenced: on June 8, 2026 Quantum Space announced its planned SPAC merger and expected Nasdaq listing under QSPC Evidence
Caveats: Most available evidence is external overlay context rather than first-party positive or negative events. Same-theme repetition across June articles is not independent confirmation. Ticker QSPC is prospective after the expected SPAC close per June 8, 2026 evidence, not confirmed as already trading under that symbol |
| 12 | Sateliot mediummedium | Opp 7 Risk 5 | Thesis: Risk remains material because later evidence indicates the Series C is being sought rather than fully closed and that Sateliot is still seeking a lead investor, with up to 50% public co-financing hoped to match private investment. That means financing completion and constellation deployment remain execution-sensitive. Why now: The sequence matters: the company launched the Series C on April 8, 2026/April 13, 2026, then later reporting on May 21, 2026 noted a first commercial launch contract, and June 24, 2026 reporting still described the round as seeking capital and a lead investor. That mix creates both opportunity and financing risk over a 1 year+ horizon. Evidence
Caveats: The reviewed sources does not provide a direct positive event row for the first commercial contract; that support is supporting article context and weaker than a structured company event row. Later dated coverage indicates financing is still being sought, which partially offsets the opportunity thesis. Undated context items exist in the reviewed sources but are not used for recency-sensitive judgments. |
| 13 | Spark Space mediummedium | Opp 5 Risk 5 | Thesis: Risk is equally meaningful because the evidence is undated supporting article context, so recency is uncertain and there is no direct evidence of launch contracts, orbital milestones, or sustained financing beyond the article summary. Why now: The reviewed sources retains undated evidence indicating Spark Space tested its engine and raised funds for an electric-pump rocket, but the article has no publication timestamp, so recency-sensitive claims should be treated cautiously. Evidence
Caveats: Article is undated, so business-state recency is uncertain. Evidence is supporting article context, not direct dated event/facts. Same article appears twice in weak-context rows and is not independent confirmation. |
| 14 | Turion Space mediummedium | Opp 7 Risk 5 | Thesis: Risk remains meaningful because the evidence still describes an early-stage company scaling from a small launched base into a persistent constellation and potentially adjacent on-orbit services, which implies execution and capital deployment risk; however, the reviewed sources contain no direct adverse event evidence. Why now: The key timing driver is the dated financing round on April 15, 2026, which the reviewed sources say positions the company to scale beyond single-mission spacecraft toward a persistent SDA constellation, a development relevant over a 1 year+ horizon. Evidence
Caveats: The reviewed sources have no direct positive or negative dated events; the case relies on supporting article context rather than stronger internal company-specific events. The company website context on May 23, 2026 is weaker than independent company-specific event evidence and should not be overweighted. Citation |
| 15 | Volta Space Technologies lowweak | Opp 4 Risk 5 | Thesis: Risk is moderate to elevated because the cited milestone is far out, execution risk is likely high, and the reviewed sources exposes no direct article summary or to confirm near-term de-risking. Why now: The rationale cites article and says the company has a 2028 demonstration planned with payload booked on Blue Ghost Mission 2, which is relevant to a 1 year+ strategic horizon but weak for immediate evidence-based ranking because no article body or is visible. Caveats: No visible representative article, quote, or in the reviewed sources body. The main cited demonstration is scheduled for 2028, so commercial payoff may sit beyond the stated 1 year+ ranking horizon. The Firefly payload linkage cannot be used as counterparty propagation evidence beyond the explicit rationale. |
| 16 | Albedo lowweak | Opp 4 Risk 4 | Thesis: Risk is also meaningful because this evidence is supporting article context only, not direct event/fact evidence in the reviewed sources' stronger fields, and the article describes Albedo as a former Earth-observation startup now focused on satellite manufacturing, implying strategic transition/execution uncertainty Why now: Why now is stronger than for most names because the reviewed sources includes a dated representative article with April 9, 2026, stating that on April 9 Albedo announced plans for its second spacecraft and a 2027 launch for its second VLEO mission Evidence
Caveats: The reviewed sources marks this as weak context only / supporting article context, not strong direct event evidence. Same article appears in multiple weak-context rows and should not be treated as independent confirmation. |
| 17 | Apex Space mediummedium | Opp 8 Risk 4 | Thesis: Risk is moderate, not because of explicit adverse evidence, but because the strongest structured support is neutral fact/context rather than explicit positive events in the reviewed sources. The evidence leans heavily on company/external article context and financing narratives, so execution risk around scaling manufacturing and converting strategic positioning into durable contracts remains an offset. Why now: Why now is strong because the key financing evidence is dated June 5, 2026 and the Northrop partnership article is dated June 1, 2026, making both recent within the 90-day recent evidence window and relevant to a 1 year+ scaling thesis. The June 5 financing event is later than the April 16 capacity/context article and therefore better reflects current business state. Evidence
Caveats: Most available evidence is neutral fact or supporting article context, not explicit positive events. Same-day repeated articles around the fundraise are not independent proof beyond corroboration. Some context sources are company-issued or article-level summaries, which are weaker than direct events. |
| 18 | Astrobase Space Technologies mediummedium | Opp 6 Risk 4 | Thesis: Risk remains material because the visible evidence is supporting article context around funding and ambition rather than proof of technical milestone completion, customer adoption, or flight success. Deep-tech engine development inherently depends on execution, but the reviewed sources does not document adverse events. Why now: The funding article is recent, with published June 12, 2026, and specifically notes this as IN-SPACe's first investment in Indian startups under the TAF scheme. That timing matters for a 1 year+ horizon because it may enable development progress over coming quarters. Evidence
Caveats: Visible evidence is only one external article summary despite the membership rationale referencing multiple structured support articles. No technical test results or customer contracts are provided in the exposed evidence. |
| 19 | Astroscale mediummedium | Opp 7 Risk 4 | Thesis: The reviewed sources also indicates Astroscale is still transitioning from technology demonstrations into repeatable commercial work, and its May 2026 financing cites an uncertain market environment, so scaling and capital-market dependence remain meaningful risks. Why now: Recency is the main reason: on June 22, 2026 SpaceNews said Astroscale was 'working to transition from technology demonstrations to a regular series of missions, bolstered by a recent capital infusion' and saw 'repeatable business opportunities' particularly among defense customers. On May 19, 2026 financing materials said the company would raise 30.6 billion yen to secure medium-to-long-term growth funding 'in anticipation of transitioning to a phase of continuous order acquisition'. On April 6, 2026 Astroscale revealed its ISSA-J1 mission scheduled for launch in 2027. Evidence
Caveats: Most within the recent evidence window evidence is supporting article context, not structured company-specific events; reviewed sources warns supporting article context is weaker than direct event/fact evidence. Same-article repeated weak-context rows are not independent confirmation. Older 2023 and 2025 articles exist in representative articles but fall outside the 90-day recent evidence window for ranking use. |
| 20 | BlackSky Technology Inc. highstrong | Opp 8 Risk 4 | Thesis: Risk is still moderate because the $99 million item is an IDIQ ceiling with only initial funding disclosed, and much of the reviewed sources support is article-context level rather than dated events; execution on next-generation payload design and constellation roadmap still matters. Why now: The why-now is supported by two dated recent wins inside the recent evidence window: on March 31, 2026 BlackSky said it received a multi-year sole-source $99 million U.S. government IDIQ and initial $2 million funding for advanced large-aperture payload design; on April 22, 2026 it announced a competitive $25 million multi-year assured contract with a major international defense customer and said it had four Gen-3 satellites on orbit and was rapidly deploying Gen-3 capacity while driving up backlog and annual recurring revenue. Evidence
Caveats: The $99 million figure is an IDIQ ceiling, not fully funded revenue at announcement; only an initial $2 million was specifically disclosed. Some corroboration repeats the same underlying announcement and should not be treated as independent evidence |